Deregulation of glutamine PRPP amidotransferase activity
AssigneesThe Board of Trustees of the University of Illinois, Purdue Research Foundation
InventorsHoward Zalkin, Janet Louise Smith, Robert Lee Switzer
Life of this patent
Estimating the term…
Abstract
The present invention is directed to a modified glutamine PRPP amidotransferase and a method of using that modified enzyme to enhance the biosynthesis of purine nucleotides. The modified glutamine PRPP amidotransferase has at least one amino acid of the allosteric A sites or the catalytic C sites of said amidotransferase substituted with a non-native amino acid, wherein the substitution reduces the sensitivity of the enzyme to end product inhibition relative to the native glutamine PRPP amidotransferase enzyme.
Claims7
A modified Bacillus glutamine PRPP amidotransferase, wherein the amino acid sequence of said modified Bacillus amidotransferase differs from that set forth in SEQ. ID NO:1 in that one or more amino acid residues at positions selected from the group consisting of 282, 283, 307, and 347 are substituted with an amino acid not native to said position or positions and wherein said modified Bacillus amidotransferase is less sensitive to end-product inhibition than is a Bacillus amidotransferase as set forth in SEQ. ID NO:1.
A nucleic acid sequence comprising a sequence encoding a modified Bacillus glutamine PRPP amidotransferase, wherein the amino acid sequence of said modified amidotransferase differs from that set forth in SEQ. ID NO:1 in that one or more amino acid residues at positions selected from the group consisting of 282, 283, 307, and 347, are substituted with an amino acid not native to said position or positions and wherein said modified Bacillus amidotransferase is less sensitive to end-product inhibition than is a Bacillus amidotransferase as set forth in SEQ. ID NO:1.
Dependencies are inferred from the claim text.